News 2016-08-06
Porton’s Semi Annual Senior Management Working Conference August 6, 2016

Chongqing, China, August 6, 2016: Porton Fine Chemicals, Ltd. held its semi-annual senior management working conference on August 6, 2016. Led by Chairman Oliver Ju and President Andrew Xu, senior executives from the Company’s R&D, Manufacturing Operations, Planning, Business Development and Key Account Management functions and overseas subsidiaries reviewed progress made during the first half of FY 2016 and plans for the second half. Porton continues to make robust advances towards its corporate goals and service mission of helping global pharmaceutical companies more efficiently realize best health outcomes for their patients through chemical process innovation and high-quality production of custom APIs and drug intermediates.
Others
More
News 2026-03-22
Porton and Jianxiang Forge Strategic Partnership to Build a New High Ground for Large-scale Peptide Drug Manufacturing
Porton and Jianxiang partner to deliver integrated peptide CDMO services from development to commercial manufacturing, offering scalable, compliant solutions for global clients.

News 2026-03-03
Porton Wins “2025 Best CRO” Award from Daewoong Pharma
Daewoong Pharma highly recognized Porton’s contributions to its drug development through active cooperation based on Porton’s excellent capabilities and expertise.